Loading...
SKAN Group Community
SWX:SKAN Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
Community Investing Ideas
US And Asian Expansion Will Unlock Pharmaceutical Market Potential
Key Takeaways Expansion into US and Asian markets, alongside robust order intake and backlog, is set to drive diversified and stable future revenue growth. Investment in high-margin aftermarket solutions, digitalization, and innovative R&D strengthens recurring revenues and maintains SKAN's leadership in advanced pharmaceutical manufacturing technologies.Read more
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
CHF 78.33
37.8% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
22.45% p.a.
Profit Margin
11.66%
Future PE
27.71x
Share price in 2028
CHF 87.64